INCY
Incyte Corporation
Latest News for INCY
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Incyte (INCY) and Dyne Therapeutics (DYN). Incyte ......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on PROCEPT BioRobotics (PRCT) and Incyte (INCY). PROCEPT BioRobotics......
Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Incyte today and set a price target of $123.00. Willey covers the Healthcare sect......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Krystal Biotech (KRYS), Incyte (INCY) and Acurx Phar......
Guggenheim analyst maintained a Buy rating on Incyte today and set a price target of $130.00. In addition to Guggenheim, Incyte also received a Buy......
In a report released on April 30, from Argus Research maintained a Buy rating on Incyte, with a price target of $115.00. The company’s shares close......
BMO Capital analyst Evan Seigerman maintained a Sell rating on Incyte today and set a price target of $75.00. According to TipRanks, Seigerman is a......
In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Incyte, with a price target of $135.00. According to Ti......
In a report released today, Evan Seigerman from BMO Capital maintained a Sell rating on Incyte, with a price target of $75.00. Seigerman covers the......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Axsome Therapeutics (AXSM), Intellia Therapeutics (NTLA) and Incy......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 11 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INCY | $97.10 | -0.1% | 1.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |